Why the study?
Does intracoronary urokinase improve recanalization, infarct size, and left ventricular function in patients with acute myocardial infarction?
Population
88 acute myocardial infarction patients evaluated within 6 hours of the onset of symptoms.
Design
Cohort
Follow-up
chronic stage
Authors
Loading...
Supports selective intracoronary urokinase use by occlusion type; leaves open randomized confirmation of functional benefit in total occlusion.
Does intracoronary urokinase improve recanalization, infarct size, and left ventricular function in patients with acute myocardial infarction?
Intracoronary urokinase achieves recanalization in acute myocardial infarction, but functional benefits regarding infarct size and left ventricular function appear limited to patients with subtotal rather than total occlusion.
Motomiya et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: